Clinical Trials Logo

Clinical Trial Summary

Cryptosporidium species are increasingly recognized as important enteric pathogens that infect a broad range of hosts including human, domestic and wild animals worldwide, causing asymptomatic or mild-to-severe gastrointestinal disease in their host species. There are 38 species of Cryptosporidium that have been described, going from amphibian parasites to mammals ones, with over 40 genotypes infecting mammals, although Cryptosporidium parvum and Cryptosporidium hominis are the two species predominantly reported in human infections. In Cairo and Sharkyia governorates in Egypt, Cryptosporidium is a common intestinal parasite among children, especially in diarrheic, preschool-aged children, with a predominance of C. hominis indicates anthroponotic rather than zoonotic transmission. Also in the sohag governorate, Cryptosporidium infection is a common intestinal parasite, as in the last five years its prevalence about 35% but there is no study clarify predominant genotype of Cryptosporidium in sohag.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05208970
Study type Observational
Source Sohag University
Contact Salwa GA Omran, assistant lecturer
Phone 01011154173
Email [email protected]
Status Recruiting
Phase
Start date March 1, 2022
Completion date November 2022

See also
  Status Clinical Trial Phase
Terminated NCT00057486 - Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients Phase 1/Phase 2
Completed NCT00507871 - Transmission and the Respiratory Tract in Cryptosporidiosis N/A
Terminated NCT00001162 - Parasitic Infections of the Gastrointestinal Tract N/A
Not yet recruiting NCT04332705 - Cryptosporidium Infection and Human Colorectal Cancer
Active, not recruiting NCT02764918 - Cryptosporidiosis and Enteropathogens in Bangladesh
Not yet recruiting NCT01695304 - Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya N/A
Terminated NCT00004986 - Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients Phase 3
Recruiting NCT04103216 - Treatment of Cryptosporidiosis N/A
Terminated NCT03341767 - A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis Phase 2
Completed NCT01699841 - Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events N/A
Active, not recruiting NCT00002158 - A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis N/A
Completed NCT00002328 - Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs N/A
Completed NCT00002248 - A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients Phase 1
Completed NCT00002027 - Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433) N/A
Completed NCT00001081 - A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium Phase 2
Completed NCT00000771 - A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3 Phase 2
Completed NCT00000980 - A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea Phase 1
Terminated NCT00001128 - Treatment of Chronic Cryptosporidiosis in AIDS Patients N/A
Completed NCT00002062 - Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients N/A
Completed NCT00002278 - A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS N/A